Pelthos Therapeutics Ratios (2023-2025) | PTHS

Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) 68.73%89.87%
EBT Margin (Quarter) -225.53%-173.24%
EBIT Margin (Quarter) -207.43%-72.74%
EBITDA Margin (Quarter) -207.43%-72.74%
Operating Margin (Quarter) -207.43%-72.74%
Net Margin (Quarter) -219.25%-131.29%
FCF Margin (Quarter) -206.03%-37.89%
Efficiency
Inventory Average (Quarter) 23.84M
Assets Average (Quarter) 2.06M3.32M2.37M1.75M1.14M0.87M63.63M128.41M
Equity Average (Quarter) -2.66M0.47M-0.81M-2.07M-3.46M-5.34M25.88M48.57M
Invested Capital (Quarter) -6.45M1.13M-0.18M-1.43M-0.66M-4.20M-6.49M58.25M38.88M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -52.54-16.89-0.00M-0.00M-11.41-9.13
Debt to Equity (Quarter) -0.12-0.72-0.09-0.81-0.03-0.02
Debt Ratio (Quarter) 7.780.050.061.600.140.16
Equity Ratio (Quarter) -66.860.28-0.07-0.67-1.98-4.61-7.890.460.30
Times Interest Earned (Quarter) -52.54-16.89-0.00M-0.00M-11.41-9.13
Valuation
Enterprise Value (Quarter) -0.10M-3.77M-2.41M-0.51M-0.51M-0.13M-0.06M-14.25M-18.02M
Return Ratios
Return on Sales (Quarter) -0.02%-0.01%
Return on Capital Employed (Quarter) 325.14%188.33%138.56%-57.26%-31.66%
Return on Assets (Quarter) -0.03%-0.05%-0.06%-0.10%0.00%0.00%
Return on Equity (Quarter) 0.07%0.04%0.02%0.02%-0.01%-0.01%